• Join
  • Contact
  • 0Shopping Cart
Medical Affairs Professional Society
  • Membership
    • Join MAPS
    • Renew Your Membership
    • Access Your Profile
    • Membership FAQ
  • Professional Development
    • Online Courses
    • Knowledge Center
      • Standards & Guidance
      • Position Papers
      • White Papers
      • Benchmark Reports
      • Webinars
      • Elevate Articles
      • Elevate Podcasts
    • Textbook
  • MasterClass
    • MasterClass
    • MasterClass Onsite
  • Partnerships
    • Industry Partnership Program
    • Partner Circle Solutions
    • Media Planner
  • Events
    • Call For Proposals FAQ
    • MAPA-MAPS Sydney Summit 2025
  • Opportunities
    • Focus Area Working Groups
    • Awards
    • Chapters
    • Get Involved
    • Mentorship Program
    • Job Postings
  • About
    • Mission, Vision & Value
    • Leadership
    • Career Resources
    • Our Team
    • Policies
    • Bylaws
  • Menu Menu
  • LinkedIn
  • X
  • Instagram
Victoria QA Featured

Medical Affairs Lessons from a 2-Month Pandemic Preview

November 3, 2020/in ACCESS, Open Access, Elevate Articles, Field Medical, Content Hub, SEARCH BY TOPIC, SEARCH BY TYPE/by Medical Affairs

As VP and Head of the Asia-Pacific Medical Affairs function at Amgen, Victoria Elegant saw COVID-19 a full two months before colleagues in other parts of the world. In fact, in January 2020 as news of COVID-19 outbreaks in China reached beyond the country’s borders, Elegant was finishing a ski trip to Switzerland. “The second I got off the phone with our crisis team, I went out and bought masks and hand sanitizer,” she says. Elegant was traveling with what she describes as a “big, international group of doctors,” and remembers that at least half the group was amazed by her reaction. “I passed out masks, saying ‘You will need these,’” Elegant says. Here the Medical Affairs Professional Society (MAPS) speaks with Elegant and colleague Ka Weng Mah, Director of Medical Capabilities, Amgen Asia Pacific about the takeaways for the practice of Medical Affairs afforded by their front-row seats to the pandemic, and also about results of a recent Amgen survey of healthcare provider preferences.

MAPS: You talked a little about Europe’s reaction to news of the pandemic – what did you see when you returned home to Hong Kong?

Victoria Elegant 300x300 1

Victoria Elegant, VP and Head of the Asia-Pacific Medical Affairs function at Amgen

Elegant: Healthcare professionals in Hong Kong knew what was coming. In Asia, we went through SARS and there is a culture of wearing masks if you are sick to protect other people. Even flying back to Hong Kong in January, everyone on the plane and in the airport was wearing masks. In the middle of it, it was intense – trying to figure out what we needed to do for our staff, for patients, how to continue clinical trials.

Mah: As early as in late Jan/early Feb, many people in Asia were even more progressive than the governments, with calls to close borders immediately. The majority, almost 98.8% in many Asian countries, also took the initiative to wear masks.

MAPS: So, effectively, you had a two-month head start on the pandemic compared with the rest of the world. Did this put you in a position to see early transformations in the practice of Medical Affairs?

Elegant: Even before the pandemic, we had seen that we needed to do things differently and had appointed a Medical Affairs digital lead in July 2019. So when hospitals suddenly wouldn’t let us do face-to-face healthcare provider interactions, in a way, we were lucky and perhaps a bit ahead of the game: We had already laid the foundation for digital.

Mah: Previously, we had aspirations to drive digital transformation but it was just experimental. Then with COVID, it meant squeezing years of work in one month. What we said is that every MSL can be e-MSL, every event can be an e-Event, and it was COVID-19 that hastened the transformation of our business – the future we were working towards, came today.

MAPS: On the organization side, digital transformation was driven by the realities of the pandemic, but did you see the same adoption from healthcare providers?

Elegant: China changed almost overnight. But Japan and Korea are conservative countries and change can be more challenging. Asia is still a face-to-face culture. For example, the more people you have in a meeting with an important person, the more you show respect. These were attitudes we had to work on. We saw that we needed to facilitate this change management and get stakeholders to accept a new way of doing things. Therefore, back in April we performed a systematic review of industry reports, followed by internal (MSL) and external (KOL) surveys, in order to identify and drive the necessary new ways of working in this peri-COVID era.

MAPS: And what do you see now in these countries?

Ka Weng Mah

Ka Weng Mah, Director of Medical Capabilities, Amgen Asia Pacific

Mah: We spent so much time educating and bringing people up to speed, then all of a sudden we had way more transformation than we could handle. Korea had practically no virtual interactions but were forced to adapt and flipped overnight and now they are embracing digital completely. Japan, as well, embraced digital but now many healthcare providers in Japan are already wanting to go back to face-to-face interactions. Perhaps there is a cultural element to this, but there’s no way we can go back. The new world will be a blended one. I think that for a more digitally open country like China, it will go 50percent digital or more, while countries like Japan and Korea may end up being somewhat less.

MAPS: There must have been some element of excitement watching these initiatives that had been moving along slowly suddenly gain momentum?

Elegant: We had to do this transformation overnight, working 24/7 to get capabilities and systems in place. Big corporations have their challenges with innovation but MSLs have to do their jobs and meetings had to go ahead. We spent a lot of time trying to support teams and engage with them and figure out how they could managethis We also had to support the teams to find a balance between the work that needs to get done and also keeping themselves mentally and physically healthy in the new way of working.

MAPS: Does all this work and all this dramatic transformation simply bring you back to the level capabilities you had before the pandemic or is there some benefit to these activities beyond simply learning how to do your old jobs in a new world?

Elegant: One of the things that’s emerged for us is patients as an even more important stakeholder. The COVID process has led to the realization that the healthcare system is set up for providers and not necessarily for patients. It’s super inconvenient – generally – to be a patient. And now we see there are things we can do to help – things like delivering clinical trials supplies to patients’ homes or providing a 6-month prescription instead of a 1-month prescription or providing an ongoing supply of medications to homes for chronic conditions. One of the big things to come out of this pandemic experience is how to work with patients to amplify their voice, especially in Asia where the patient voice hasn’t been so strong. This inclusion of patients as core stakeholders opens our eyes to other non-traditional stakeholders in the patient-care continuum, for example caregivers, physical therapists, pharmacists, nurses, occupational therapists and others. It is not just physicians in this healthcare ecosystem and digital transformation gives us the opportunity to engage with some of these categories that have traditionally been overlooked.

MAPS: And how do you reach these people?

Mah: The gist is that someone needs to engage those important stakeholders as partners, not just when we need them every three years. The patients are, and will remain, at the core in everything we do. So this is our immediate priority to sort – who, when, how to reach out to them. Then we have to go sector by sector: A more democratized world, the patient voice, more virtual and digital as well so that everyone gets the information they need. I don’t think we’ve figured it out exactly who and how to reach out.

Elegant: One thing we learnt from the survey we conducted (see White paper) is that doctors want scientific interactions, so maybe they’re prioritizing their interactions with Medical Affairs, or maybe it’s just easier to have remote interactions with us. We find that it’s easier to have a remote interaction if you have an established relationship first, but setting up that relationship remotely can be challenging.

MAPS: Do you have any other takeaways from your survey of HCP preferences for continued MSL interactions?

Elegant: Certainly. If I were to point to one area of our report, I would look to our recommendations for the future. First, putting patients and their caregivers in addition to HCPs at the core/center of Medical activities. Second, successful Medical teams will use innovative, modern approaches in scientific engagements. And finally, leading Medical teams need to invest in (and incorporate) rapid and radical digital transformation to ways of working. We are focused on making sure that these transformations will be executed and embedded into our ways of working, in order to improve patient outcomes and standards of care in Asia Pacific.

 

https://medicalaffairs.org/wp-content/uploads/2020/11/Victoria-QA-Featured.png 321 845 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2020-11-03 14:04:302022-11-04 09:05:53Medical Affairs Lessons from a 2-Month Pandemic Preview
Field Medical Podcast 1

Field Medical Stakeholders: Partnering for Today and Tomorrow (Episode 1 — Global Communications)

November 2, 2020/in Competency, ACCESS, Open Access, External Scientific Engagement, Customer Engagement & Scientific Comms, Elevate Podcasts, Field Medical, Content Hub, Medical Communications, SEARCH BY TOPIC, SEARCH BY TYPE/by Medical Affairs

Medical Affairs thought leaders discuss the function, activities and opportunities for compliant collaboration with key internal partners.

Read more
https://medicalaffairs.org/wp-content/uploads/2020/11/Field-Medical-Podcast-1.png 321 845 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2020-11-02 10:08:352023-11-13 10:05:13Field Medical Stakeholders: Partnering for Today and Tomorrow (Episode 1 — Global Communications)
TownHall 1200x360 pxC

MAPS Global Town Hall: Digital Innovation in Medical Affairs and the Evolution of Field Medical During the Pandemic and Beyond

October 15, 2020/in Competency, ACCESS, Open Access, Webinars, Customer Engagement & Scientific Comms, Digital, Digital Trends & Opportunities, Field Medical, Content Hub, SEARCH BY TOPIC, SEARCH BY TYPE/by Medical Affairs

This special 75-minute MAPS Global Town Hall focuses on the challenges that are arising from the global Covid-19 pandemic and the emerging opportunity for Medical Affairs to provide strategic leadership.

Read more
https://medicalaffairs.org/wp-content/uploads/2020/09/TownHall-1200x360-pxC.jpg 360 1200 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2020-10-15 13:02:072023-11-13 10:07:43MAPS Global Town Hall: Digital Innovation in Medical Affairs and the Evolution of Field Medical During the Pandemic and Beyond
MONOCL Podcast 1 Featured

PODCAST: Expert Engagement — Driving the Strategic Impact of Medical Affairs

October 12, 2020/in Competency, ACCESS, Open Access, External Scientific Engagement, Customer Engagement & Scientific Comms, Elevate Podcasts, Field Medical, Content Hub, Content HUB Featured, SEARCH BY TOPIC, SEARCH BY TYPE/by Medical Affairs

MAPS in conversation with Robert Groebel, VP Global Strategy, MONOCL, and Danie du Plessis, VP Medical Affaris, Kyowa Kirin

Read more
https://medicalaffairs.org/wp-content/uploads/2020/10/MONOCL-Podcast-1-Featured.png 321 845 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2020-10-12 06:23:032023-11-13 10:08:28PODCAST: Expert Engagement — Driving the Strategic Impact of Medical Affairs
Ralph.Rewers.Interview

Interview: Field Medical’s Broad Impact on Patients and Organizations

May 10, 2020/in Competency, SEARCH BY TYPE, Open Access, External Scientific Engagement, Customer Engagement & Scientific Comms, Innovate Articles, Field Medical/by Medical Affairs

Ralph Rewers, Sr Director, Global Field Medical Excellence at AbbVie, shares how Field Medical professionals are in a position to impact thousands of patients. At the MAPS 2020 Global Annual Meeting, Dr. Rewers encourages Field Medical professionals to step into the shoes of the individuals they’re speaking with to better understand their beliefs and behaviors, so organizations can better tailor medical communications to how they receive scientific data.

 

If the video above does not play, or to view full screen, CLICK HERE to open in a new window.

 

Download the Presentation

Members may also download a PDF copy of the slides from the Field Medical program from the MAPS 2020 Global Annual Meeting as well as a recording of the session in the Community Portal. Not a member and wish to access the slides? Membership is only $250 USD per year ($425 for a 2-year subscription) and includes access to all new live Webinars, all on-demand Webinars (over 50 Webinars and growing each month), discussion forums to share best practices and questions with over 4,000 Medical Affairs professionals from across the globe, copies of past meeting presentations, white papers, standards & guidance tools and templates, and much, much more. Click here for membership details or to sign up: https://medicalaffairs.org/membership/

https://medicalaffairs.org/wp-content/uploads/2020/05/Ralph.Rewers.Interview.png 321 845 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2020-05-10 16:11:162024-04-26 11:51:53Interview: Field Medical’s Broad Impact on Patients and Organizations
5

Podcast: The Dynamic World of Field Medical: Are you a driver or passenger?

February 28, 2020/in Competency, Open Access, External Scientific Engagement, Customer Engagement & Scientific Comms, Elevate Podcasts, Field Medical/by Medical Affairs

Click a thumbnail below to listen to the episode. 

 

       

 

.     

CLICK HERE to subscribe to the Elevate Podcast Channel on Apple iTunes.

https://medicalaffairs.org/wp-content/uploads/2020/04/5.png 321 845 Medical Affairs https://medicalaffairs.org/wp-content/uploads/2025/03/MAPS-Logo-R-NoTagLine-2048x679-1.png Medical Affairs2020-02-28 19:01:252023-11-13 10:26:49Podcast: The Dynamic World of Field Medical: Are you a driver or passenger?
Page 4 of 41234
MAPS LinkedIn

Elevate Podcast Channel

Popular
  • Murali Gopal Featured
    Why Good Science is Good Business: A Conversation with Murali...October 15, 2020 - 12:05 PM
  • Optimizing Early-Stage Product Development: Is it ever “Too...July 10, 2025 - 1:31 PM
  • Best Practices for Managing the Life Cycle of an Investigator-Initiated...May 4, 2018 - 10:44 AM
  • Now More Than Ever, HEOR Plays a Central Role in Forging...June 24, 2018 - 10:51 AM
  • Compliance Considerations in Medical/Commercial Collabo...August 30, 2018 - 10:35 AM
  • Medical Affairs Excellence and Ethics & Compliance...August 30, 2018 - 10:41 AM

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Follow Us
  • Link to X
  • Link to LinkedIn
  • Link to Instagram
Subscribe to MAPS Newsletter
MAPS Program Support Services
Policies and Positions
Scroll to top
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}